Idiopathic thrombocytopenic purpura. Diagnosis, development, prognosis, treatment
Wautier, J.L.
La Revue du Praticien 45(7): 909-910
1995
ISSN/ISBN: 0035-2640 PMID: 7761762 Document Number: 443258
Document emailed within 1 workday
Related Documents
Arendt, T.; Nizze, H.; Konrad, H. 1989: Long-term prognosis of the results of splenectomy in idiopathic thrombocytopenic purpura Folia Haematologica 116(2): 337-342Bloch Thomsen, P.E. 1971: Treatment of idiopathic thrombocytopenic purpura Nordisk Medicin 85(32): 968
Kreuger, A. 1983: Treatment of children with idiopathic thrombocytopenic purpura Lakartidningen 80(45): 4294-4296
Ciepielewska, D.; Ochocka, M. 1988: Immunoglobulins in the treatment of chronic idiopathic thrombocytopenic purpura Polski Tygodnik Lekarski 43(7): 221-224
Tasić, J.; Milenović, M.; Drasković, S.; Vukicević, T.; Macukanović, L.; Kitić, L.; Bakić, M. 1994: Treatment and results of therapy in chronic idiopathic thrombocytopenic purpura Srpski Arhiv Za Celokupno Lekarstvo 122(Suppl 1): 103-104
Cancelas, J.A.; Alvarez, F.; Navarro, J.L.; César, J.M. 1994: Splenic irradiation as a treatment for chronic idiopathic thrombocytopenic purpura Sangre 39(2): 152-153
Jamali, F.; Lemery, S.; Ayalew, K.; Robottom, S.; Robie-Suh, K.; Rieves, D.; Pazdur, R. 2009: Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura Oncology 23(8): 704-709
Genova, R.; Marchi, A.; Zaverio, S. 1977: Our experiences in the treatment of chronic idiopathic thrombocytopenic purpura (ITP) using vincristine Minerva Pediatrica 29(39): 2399-2405
Mazzucconi, M.G.; Francesconi, M.; Fidani, P.; Di Nucci, G.; Gandolfo, G.M.; Afeltra, A.; Masala, C.; Di Prima, M.; Rocchi, G.; Resta, S. 1985: Treatment of idiopathic thrombocytopenic purpura (ITP): results of a multicentric protocol Haematologica 70(4): 329-336
JiJi, R.M.; Firozvi, T.; Spurling, C.L. 1973: Chronic idiopathic thrombocytopenic purpura. Treatment with steroids and splenectomy Archives of Internal Medicine 132(3): 380-383
Fey, M.F.; Beck, E.A. 1986: Psychogenic purpura, idiopathic thrombocytopenic purpura, and platelet dysfunction in the same patient Journal of Clinical Psychiatry 47(7): 386-387
Ambriz-Fernández, R.; Sinco-Angeles, A.; Avilés-Miranda, A.; Chávez-Vela, J.; Pizzuto-Chávez, J. 1983: Idiopathic thrombocytopenic purpura in 225 adult cases. use of delayed action prednisone in chronic purpura Gaceta Medica de Mexico 119(4): 164-168
Wang, W.; Yu, Q.-H.; Zhang, H.-Y.; Chu, X.-X.; Chen, F.; Zhang, C.-Q.; Zhou, Y.-H.; Hou, M. 2008: Rituximab treatment for adults with steroid-resistant idiopathic thrombocytopenic purpura Zhonghua Nei Ke Za Zhi 47(3): 225-227
Hathirat, P.; Isarangkura, P.; Songsithichok, S.; Pipatanakul, S.; Numhom, S. 1986: Idiopathic thrombocytopenic purpura in childhood. a comparison of the effect of treatment with 1 mg/kg and 2 mg/kg/day of prednisolone Journal of the Medical Association of Thailand 69(Suppl 2): 62-68
Laosombat, V.; Wiriyasateinkul, A.; Wongchanchailert, M. 2000: Intravenous gamma globulin for treatment of chronic idiopathic thrombocytopenic purpura in children Journal of the Medical Association of Thailand 83(2): 160-168
Wang, X.-q.; Lin, G.-w. 2004: Treatment of idiopathic thrombocytopenic purpura in pregnancy using method of evidence-based medicine Zhonghua Yi Xue Za Zhi 84(19): 1662-1663
Usenko, K.S. 1979: Effectiveness of the surgical treatment of idiopathic thrombocytopenic purpura in children taking into account the late results Pediatriia Akusherstvo i Ginekologiia 3: 26-28
Stasi, R. 2010: Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpura Current Opinion in Molecular Therapeutics 12(6): 734-740
Schiavotto, C.; Castaman, G.; Rodeghiero, F. 1993: Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol Haematologica 78(6 Suppl 2: 29-34
Vyhovs'ka, I.I.; Karol', I.S.; Fedak, L.M.; Tsytsyk, O.I. 2004: Use of recombinant activated factor VIi (NovoSeven) in the treatment of a patient with idiopathic thrombocytopenic purpura complicated with subarachnoid and parenchimatous hemorrhage Likars'ka Sprava 7: 77-81